Abstract
Assembly and deposition of amyloid ß-protein (Aß) is an invariable and fundamental event in the pathological process of Alzheimer’s disease (AD). To decipher the AD pathogenesis and also to develop disease-modifying drugs for AD, clarification of the molecular mechanism underlying the Aß assembly into amyloid fibrils in the brain has been a crucial issue. GM1-ganglioside-bound Aß (GAß), with unique molecular characteristics such as having an altered conformation and the capability to accelerate Aß assembly, was discovered in an autopsied brain showing early pathological changes of AD in 1995. On the basis of these findings, it was hypothesized that GAß is an endogenous seed for amyloid fibril formation in the AD brain. A body of evidence that supports this GAß hypothesis has been growing over this past 20 years. In this article, seminal GAß studies that have been carried out to date, including recent ones using unique animal models, are reviewed.
Similar content being viewed by others
References
Yanagisawa, K., Odaka, A., Suzuki, N., Ihara, Y.: GM1 ganglioside-bound amyloid ß-protein (Aß): a possible form of preamyloid in Alzheimer’s disease. Nat. Med. 1, 1062–1066 (1995)
Hayashi, H., Kimura, N., Yamaguchi, H., Hasegawa, K., Yokoseki, T., Shibata, M., Yamamoto, N., Michikawa, M., Yoshikawa, Y., Terao, K., Matsuzaki, K., Lemere, C.A., Selkoe, D.J., Naiki, H., Yanagisawa, K.: A seed for Alzheimer amyloid in the brain. J. Neurosci. 24(20), 4894–4902 (2004). doi:10.1523/JNEUROSCI. 0861-04.2004
Yanagisawa, K.: Role of gangliosides in Alzheimer’s disease. Biochim. Biophys. Acta 1768(8), 1943–1951 (2007)
Ariga, T., McDonald, M.P., Yu, R.K.: Role of ganglioside metabolism in the pathogenesis of Alzheimer’s disease- a review. J. Lipid Res. 49(6), 1157–1175 (2008). doi:10.1194/jlr. R800007-JLR200
Matsuzaki, K., Kato, K., Yanagisawa, K.: Aβ polymerization through interaction with membrane gangliosides. Biochim. Biophys. Acta 1801(8), 868–877 (2010). doi:10.1016/j.bbalip.2010.01.008
Knight, E.M., Williams, H.N., Stevens, A.C., Kim, S.H., Kottwitz, J.C., Morant, A.D., Steele, J.W., Klein, W.L., Yanagisawa, K., Boyd, R.E., Lockhart, D.J., Sjoberg, E.R., Ehrlich, M.E., Wustman, B.A., Gandy, S.: Evidence that small molecule enhancement of β-hexosaminidase activity corrects the behavioral phenotype in Dutch APP(E693Q) mice through reduction of ganglioside-bound Aβ. Mol. Psychiatry (2014). doi:10.1038/mp.2014.135
Hong, S., Ostaszewski, B.L., Yang, T., O’Malley, T.T., Jin, M., Yanagisawa, K., Li, S., Bartels, T., Selkoe, D.J.: Soluble Aβ oligomers are rapidly sequestered from brain ISF in vivo and bind GM1 ganglioside on cellular membranes. Neuron 82(2), 308–319 (2014). doi:10.1016/j.neuron.2014.02.027
Okabayashi, S., Shimozawa, N., Yasutomi, Y., Yanagisawa, K., Kimura, N.: Diabetes mellitus accelerates Aß pathology in brain accompanied by enhanced GAß generation in non-human primates. PLoS One (2015)
McLaurin, J., Franklin, T., Fraser, P.E., Chakrabartty, A.: Structural transitions associated with the interaction of Alzheimer β-amyloid peptides with gangliosides. J. Biol. Chem. 273(8), 4506–4515 (1998)
Kakio, A., Nishimoto, S., Yanagisawa, K., Kozutsumi, Y., Matsuzaki, K.: Interactions of amyloid β-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid. Biochemistry 41(23), 7385–7390 (2002). doi:10.1074/jbc.M100252200
Williamson, M.P., Suzuki, Y., Bourne, N.T., Asakura, T.: Binding of amyloid β-peptide to ganglioside micelles is dependent on histidine-13. Biochem. J. 397(3), 483–490 (2006). doi:10.1042/BJ20060293
Fezoui, Y., Teplow, D.B.: Kinetic studies of amyloid β-protein fibril assembly. Differential effects of alpha-helix stabilization. J. Biol. Chem. 277(40), 36948–36954 (2002). doi:10.1074/jbc.M204168200
Utsumi, M., Yamaguchi, Y., Sasakawa, H., Yamamoto, N., Yanagisawa, K., Kato, K.: Up-and-down topological mode of amyloid β-peptide lying on hydrophilic/hydrophobic interface of ganglioside clusters. Glycoconj. J. 26(8), 999–1006 (2009). doi:10.1007/s10719-008-9216-7
Yagi-Utsumi, M., Kameda, T., Yamaguchi, Y., Kato, K.: NMR characterization of the interactions between lyso-GM1 aqueous micelles and amyloid β. FEBS Lett. 584(4), 831–836 (2010). doi:10.1016/j.febslet.2010.01.005
Ikeda, K., Yamaguchi, T., Fukunaga, S., Hoshino, M., Matsuzaki, K.: Mechanism of amyloid β-protein aggregation mediated by GM1 ganglioside clusters. Biochemistry 50(29), 6433–6440 (2011). doi:10.1021/bi200771m
Hoshino, T., Mahmood, M.I., Mori, K., Matsuzaki, K.: Binding and aggregation mechanism of amyloid β-peptides onto the GM1 ganglioside-containing lipid membrane. J. Phys. Chem. B 117(27), 8085–8094 (2013). doi:10.1021/jp4029062
Yagi-Utsumi, M., Matsuo, K., Yanagisawa, K., Gekko, K., Kato, K.: Spectroscopic characterization of intermolecular interaction of amyloid β promoted on GM1 micelles. Int. J. Alzheimers Dis. 2011, 925073 (2010). doi: 10.4061/2011/925073
Manna, M., Mukhopadhyay, C.: Binding, conformational transition and dimerization of amyloid-β peptide on GM1-containing ternary membrane: insights from molecular dynamics simulation. PLoS ONE 8(8), e71308 (2013). doi:10.1371/journal.pone.0071308
Kakio, A., Nishimoto, S.I., Yanagisawa, K., Kozutsumi, Y., Matsuzaki, K.: Cholesterol-dependent formation of GM1 ganglioside-bound amyloid β-protein, an endogenous seed for Alzheimer amyloid. J. Biol. Chem. 276(27), 24985–24990 (2001)
Yuyama, K., Yanagisawa, K.: Sphingomyelin accumulation provides a favorable milieu for GM1 ganglioside-induced assembly of amyloid ß-protein. Neurosci. Lett. 481(3), 168–172 (2010). doi:10.1016/j.neulet.2010.06.080
Mori, K., Mahmood, M.I., Neya, S., Matsuzaki, K., Hoshino, T.: Formation of GM1 ganglioside clusters on the lipid membrane containing sphingomyeline and cholesterol. J. Phys. Chem. B 116(17), 5111–5121 (2012). doi:10.1021/jp207881k
Fantini, J., Yahi, N., Garmy, N.: Cholesterol accelerates the binding of Alzheimer’s β-amyloid peptide to ganglioside GM1 through a universal hydrogen-bond-dependent sterol tuning of glycolipid conformation. Front. Physiol. 4, 120 (2013). doi:10.3389/fphys.2013.00120
Matsubara, T., Iijima, K., Yamamoto, N., Yanagisawa, K., Sato, T.: Density of GM1 in nanoclusters is a critical factor in the formation of a spherical assembly of amyloid β-protein on synaptic plasma membranes. Langmuir 29(7), 2258–2264 (2013). doi:10.1021/la3038999
Oikawa, N., Hatsuta, H., Murayama, S., Suzuki, A., Yanagisawa, K.: Influence of APOE genotype and the presence of Alzheimer’s pathology on synaptic membrane lipids of human brains. J. Neurosci. Res. 92(5), 641–650 (2014). doi:10.1002/jnr.23341
Cataldo, A.M., Peterhoff, C.M., Troncoso, J.C., Gomez-Isla, T., Hyman, B.T., Nixon, R.A.: Endocytic pathway abnormalites precede amyloid ß deposition in sporadic Alzheimer’s disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am. J. Pathol. 157(1), 277–286 (2000)
Yuyama, K., Yamamoto, N., Yanagisawa, K.: Chloroquine-induced endocytic pathway abnormalities: cellular model of GM1 ganglioside-induced Aß fibrillogenesis in Alzheimer’s disease. FEBS Lett. 580(30), 6972–6976 (2006)
Yuyama, K., Yanagisawa, K.: Late endocytic dysfuntion as a putative cause of amyloid fibril formation in Alzheimer’s disease. J. Neurochem. 109(5), 1250–1260 (2009). doi:10.1111/j.1471-4159.2009.06046.x
Keilani, S., Lun, Y., Stevens, A.C., Williams, H.N., Sjoberg, E.R., Khanna, R., Valenzano, K.J., Checler, F., Buxbaum, J.D., Yanagisawa, K., Lockhart, D.J.: Wustman BA, Gandy S.: Lysosomal dysfunction in a mouse model of Sandhoff disease leads to accumulation of ganglioside-bound amyloid-β peptide. J. Neurosci. 32(15), 5223–5236 (2012). doi:10.1523/JNEUROSCI. 4860-11.2012
Oikawa, N., Matsubara, T., Fukuda, T., Yasumori, H., Hatsuta H., Murayama, S., Sato, T., Suzuki, A., Yanagisawa, K.: Imbalance in fatty-acid-chain length of gangliosides triggers Alzheimer amyloid deposition. PLoS One (2015)
Jarrett, J.T., Lansbury, P.T.: Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB. Biochemistry 31(49), 12345–12352 (1992)
Jarrett, J.T., Lansbury, P.T.: Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer’s disease and scrapie? Cell 73(6), 1055–1058 (1993)
Esler, W.P., Stimson, E.R., Jennings, J.M., Vinters, H.V., Ghilardi, J.R., Lee, J.P., Mantyh, P.W., Maggio, J.E.: Alzheimer’s disease amyloid propagation by a template-dependent dock-lock mechanism. Biochemistry 39(21), 6288–6295 (2000)
Okada, T., Ikeda, K., Wakabayashi, M., Ogawa, M., Matsuzaki, K.: Formation of toxic Aβ(1–40) fibrils on GM1 ganglioside-containing membranes mimicking lipid rafts: polymorphisms in Aβ(1–40) fibrils. J. Mol. Biol. 382(4), 1066–1074 (2008). doi:10.1016/j.jmb.2008.07.072
Fukunaga, S., Ueno, H., Yamaguchi, T., Yano, Y., Hoshino, M., Matsuzaki, K.: GM1 cluster mediates formation of toxic Aβ fibrils by providing hydrophobic environments. Biochemistry 51(41), 8125–8131 (2012). doi:10.1021/bi300839u
Acknowledgments
This work was supported by the Research Funding of the Longevity Sciences (25–19) from the National Center for Geriatrics and Gerontology.
Conflict of interest
The author declare that he is free from conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yanagisawa, K. GM1 ganglioside and Alzheimer’s disease. Glycoconj J 32, 87–91 (2015). https://doi.org/10.1007/s10719-015-9579-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10719-015-9579-5